Long-term safety of growth hormone replacement after CNS irradiation.
Affiliation
Department of Endocrinology, The Christie, Manchester Academic Health Science Centre, Wilmslow Road, Manchester M20 4BX, United Kingdom.Issue Date
2011-09
Metadata
Show full item recordAbstract
Radiotherapy is a central component in the treatment of many brain tumors, but long-term sequelae include GH deficiency and increased risk of secondary neoplasms. It is unclear whether replacement therapy with GH (GHRT) further increases this risk.Citation
Long-term safety of growth hormone replacement after CNS irradiation. 2011, 96 (9):2756-61 J Clin Endocrinol MetabJournal
Journal of Clinical Endocrinology and MetabolismDOI
10.1210/jc.2011-0112PubMed ID
21715535Type
ArticleLanguage
enISSN
1945-7197ae974a485f413a2113503eed53cd6c53
10.1210/jc.2011-0112